Article Text

Download PDFPDF
OP53 High polygenic predisposition for ADHD and a greater risk of all-cause mortality: a large population-based longitudinal study
  1. Olesya Ajnakina1,2,
  2. Diana Shamsutdinova2,
  3. Theresa Wimberley3,4,5,
  4. Søren Dalsgaard3,6,7,
  5. Andrew Steptoe1
  1. 1Behavioural Science and Health, University College London, London, UK
  2. 2Biostatistics and Health Informatics, King’s College London, London, UK
  3. 3Economics and Business, Aarhus University, Aarhus, Denmark
  4. 4Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark
  5. 5Centre for Integrated Register-based Research (CIRRAU), Aarhus University, Aarhus, Denmark
  6. 6Child and Adolescent Psychiatry, Gentofte Hospital, Copenhagen, Denmark
  7. 7Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark


Background Attention deficit hyperactivity disorder (ADHD) is a highly heritable, neurodevelopmental disorder known to associate with more than double the risk of death compared with people without ADHD. Because most research on ADHD has focused on children and adolescents, among whom death rates are relatively low, the impact of a high polygenic predisposition to ADHD on accelerating mortality risk in older adults is unknown. Thus, the aim of the study was to investigate if a high polygenetic predisposition to ADHD exacerbates the risk of all-cause mortality in older adults from the general population in the UK.

Methods Utilising data from the English Longitudinal Study of Ageing, which is an ongoing multidisciplinary study of the English population aged ≥50 years, polygenetic scores for ADHD were calculated using summary statistics for 1) ADHD (PGS-ADHDsingle), and 2) chronic obstructive pulmonary disease and younger age of giving first birth, which were shown to have a strong genetic correlation with ADHD using the multi-trait analysis of genome-wide association summary statistics; this polygenic score was referred to as PGS-ADHDmulti-trait. All-cause mortality was ascertained from the National Health Service central register that captures all deaths occurring in the UK.

Results The sample comprised 7133 participants with a mean age of 64.7 years (SD=9.5, range=50–101); of these, 1778 (24.9%) died during a period of 11.2 years. PGS-ADHDsingle was associated with a greater risk of all-cause mortality (Hazard Ratio [HR]=1.06, 95%CI=1.02–1.12, p=0.010); further analyses showed this relationship was significant in men (HR=1.07, 95%CI=1.00–1.14, p=0.043). Risk of all-cause mortality increased by an approximate 11% for one standard deviation increase in PGS-ADHDmulti-trait (HR=1.11, 95%CI=1.06–1.16, p<0.001). When the model was run separately for men and women, the association between PGS-ADHDmulti-trait and an increased risk of all-cause mortality was significant in men (HR=1.10, 95%CI=1.03–1.18, p=0.003) and women (HR=1.11, 95%CI=1.04–1.19, p=0.003).

Conclusion Polygenic predisposition to ADHD confers increased risk for all-cause mortality in the general population of adults aged 50 years old and onwards. Our results further suggest that to fully capture the genetic risk of ADHD, it is imperative to incorporate genetic information contained in traits with an overlapping molecular basis. Even though PGSs can be seen as unconfounded proxies for the life-time predisposition to ADHD, their low generalisability across populations is noteworthy. This is because the construction of PGSs is mainly dependent on the availability of summary statistics from the genome wide association studies, which are currently predominately based on European participants.

  • ADHD
  • genetics
  • mortality
  • older adults

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.